We found a number of metabolites that changed between PCa and control subjects, and even if these changes were marginally significant when analyzing each metabolite independently, they could be predictive of PCa status when combined together.
← all excerpts
A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer.
1
—
—